Skip to main content
Fig. 4 | Clinical Epigenetics

Fig. 4

From: Clinical and epigenetic features of colorectal cancer patients with somatic POLE proofreading mutations

Fig. 4

Methylation analysis of the promoter region in the MGMT and SFRP2 gene. a Schematic depiction of two regions (Mp and Eh region) of the MGMT promoter for methylation, and results of a panel of representative fluorescent bisulphite PCR following restriction enzyme analysis. Methylated samples had the new fragment cleaved by the restriction enzyme (black triangles). White triangles represent unmethylated alleles. M and U denote methylated and unmethylated, respectively. A grey bar denotes an untranslated exon. b The frequencies of MGMT promoter methylation status among the POLE, MSI-M, MSI-U, and non-MSI groups. Extensive methylation is defined as 5.0% or more methylation on both Mp and Eh regions. Partial methylation is defined as 5.0% or more methylation on either Eh or Mp region. c Schematic depiction of two regions (R1 and R2 region) of the SFRP2 promoter for methylation, and results of a panel of representative fluorescent bisulphite PCR following restriction enzyme analysis. Methylated samples had the new fragment cleaved by the restriction enzyme (black triangles). White triangles represent unmethylated alleles. M and U denote methylated and unmethylated, respectively. A black bar denotes translated exon. d The frequencies of SFRP2 promoter methylation status among the POLE, MSI-M, MSI-U, and non-MSI groups. Extensive methylation is defined as 5.0% or more methylation on both R1 and R2 region. Partial methylation is defined as 5.0% or more methylation on either R1 or R2 region. The number in each column denotes the number of samples classified in each category divided by MGMT or SFRP2 methylation status

Back to article page